Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes | Zendy

Thomas Reinehr | Zendy; Beate Karges | Zendy; Thomas Meißner | Zendy; Susanna Wiegand | Zendy; Maria Fritsch | Zendy; Reinhard W. Holl | Zendy; Joachim Woelfle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes

Author(s) -

Thomas Reinehr,

Beate Karges,

Thomas Meißner,

Susanna Wiegand,

Maria Fritsch,

Reinhard W. Holl,

Joachim Woelfle

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-2192

Subject(s) - medicine , interquartile range , fgf21 , adiponectin , body mass index , endocrinology , glycated hemoglobin , leptin , confidence interval , type 2 diabetes , obesity , diabetes mellitus , insulin resistance , fibroblast growth factor , receptor

Hepatokines such as fetuin-A or fibroblast growth factor 21 (FGF21) are reasonable candidates affecting the pathophysiology of type 2 diabetes mellitus (T2DM). However, studies in humans at the onset of disease are scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research